E. T. Liu

HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells (2007)

Mohankumar, K.M., Xu, X.Q., Zhu, T., Kannan, N., Miller, L.D., Liu, E.T., ...

Expression of homeobox A1 (HOXA1) results in oncogenic transformation of immortalized human mammary epithelial cells with aggressive tumor formation in vivo. However, the mechanisms by which HOXA1...

Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A (2005)

Reid, G., Metivier, R., Denger, S., Ibberson, D., Ivacevic, T., ...

Valproate (VPA) and trichostatin A (TSA), inhibitors of zinc-dependent deacetylase activity, induce reduction in the levels of mRNA encoding oestrogen receptor-alpha (ERalpha), resulting in...

Breast cancer: Gene profile and response to treatment (2005)

Smeds, J., Miller, L. D., Bjöhle, J., Hall, P., Klaar, S., Liu, E. T., ...

Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.

Fridell, Y W, Jin, Y, Quilliam, L A, Burchert, A, McCloskey, P, Spizz, G, ...

To understand the mechanism of Axl signaling, we have initiated studies to delineate downstream components in interleukin-3-dependent 32D cells by using a chimeric receptor containing the recombinant...

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

O'Bryan, J P, Frye, R A, Cogswell, P C, Neubauer, A, Kitch, B, Prokop, C, ...

Using a sensitive transfection-tumorigenicity assay, we have isolated a novel transforming gene from the DNA of two patients with chronic myelogenous leukemia. Sequence analysis indicates that the...

The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura.

Schneider, P A, Rayner, A A, Linker, C A, Schuman, M A, Liu, E T, Hohn, D C

Current treatment modalities for thrombotic thrombocytopenic purpura (TTP) include plasmapheresis (PP), splenectomy, steroids, dextran, other antiplatelet agents, and vinca alkaloids. Prior to the...

Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.

Fridell, Y W, Jin, Y, Quilliam, L A, Burchert, A, McCloskey, P, Spizz, G, ...

To understand the mechanism of Axl signaling, we have initiated studies to delineate downstream components in interleukin-3-dependent 32D cells by using a chimeric receptor containing the recombinant...

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

O'Bryan, J P, Frye, R A, Cogswell, P C, Neubauer, A, Kitch, B, Prokop, C, ...

Using a sensitive transfection-tumorigenicity assay, we have isolated a novel transforming gene from the DNA of two patients with chronic myelogenous leukemia. Sequence analysis indicates that the...

The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura.

Schneider, P A, Rayner, A A, Linker, C A, Schuman, M A, Liu, E T, Hohn, D C

Current treatment modalities for thrombotic thrombocytopenic purpura (TTP) include plasmapheresis (PP), splenectomy, steroids, dextran, other antiplatelet agents, and vinca alkaloids. Prior to the...